Toxic epidermal necrolysis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 30: | Line 30: | ||
== Case Studies == | == Case Studies == | ||
[[Toxic epidermal necrolysis case study one|Case #1]] | [[Toxic epidermal necrolysis case study one|Case #1]] | ||
==Related Chapters== | |||
== | |||
* [[Stevens-Johnson syndrome]] | * [[Stevens-Johnson syndrome]] | ||
==External | ==External Links== | ||
* {{MerckHome|18|203|e}} | * {{MerckHome|18|203|e}} | ||
* [http://www.sjsupport.org Stevens Johnson Syndrome Foundation] | * [http://www.sjsupport.org Stevens Johnson Syndrome Foundation] |
Revision as of 01:01, 11 February 2013
Toxic epidermal necrolysis Microchapters |
Differentiating Toxic Epidermal Necrolysis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Toxic epidermal necrolysis On the Web |
American Roentgen Ray Society Images of Toxic epidermal necrolysis |
Risk calculators and risk factors for Toxic epidermal necrolysis |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Lyell's syndrome; TEN
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Toxic epidermal necrolysis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies